Menactra Supply Shortage Will Be Resolved By Fall, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
CDC recommends Sanofi Pasteur’s oral meningococcal disease vaccine Menomune as an “acceptable alternative” to the firm’s intramuscular vaccine.
You may also be interested in...
Sanofi Vaccine Sales Jump 50 Percent In Q3
Performance of vaccines business helps offset slight decline in pharmaceuticals revenues, hard hit by Ambien IR generics.
Sanofi Vaccine Sales Jump 50 Percent In Q3
Performance of vaccines business helps offset slight decline in pharmaceuticals revenues, hard hit by Ambien IR generics.
Menactra Launch Slated For March On Heels Of Broad CDC Recommendations
Advisory Committee on Immunization Practices recommends routine meningococcal vaccination for adolescents ages 11-12, those entering high school and college freshmen living in dorms. Panel acknowledges that broad recommendations could lead to supply constraints, Sanofi says.